CN112136993A - 一种药食同源发酵饮品及其制备方法 - Google Patents
一种药食同源发酵饮品及其制备方法 Download PDFInfo
- Publication number
- CN112136993A CN112136993A CN202011003831.6A CN202011003831A CN112136993A CN 112136993 A CN112136993 A CN 112136993A CN 202011003831 A CN202011003831 A CN 202011003831A CN 112136993 A CN112136993 A CN 112136993A
- Authority
- CN
- China
- Prior art keywords
- parts
- cinnamon
- galangal
- raw materials
- blood
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000019985 fermented beverage Nutrition 0.000 title claims abstract description 38
- 238000002360 preparation method Methods 0.000 title abstract description 17
- 239000002994 raw material Substances 0.000 claims abstract description 33
- 235000008708 Morus alba Nutrition 0.000 claims abstract description 32
- 235000006886 Zingiber officinale Nutrition 0.000 claims abstract description 31
- 235000008397 ginger Nutrition 0.000 claims abstract description 31
- 244000223760 Cinnamomum zeylanicum Species 0.000 claims abstract description 27
- 235000017803 cinnamon Nutrition 0.000 claims abstract description 27
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 26
- 244000062241 Kaempferia galanga Species 0.000 claims abstract description 25
- 235000013421 Kaempferia galanga Nutrition 0.000 claims abstract description 25
- 240000000249 Morus alba Species 0.000 claims abstract description 25
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 25
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 25
- 235000006040 Prunus persica var persica Nutrition 0.000 claims abstract description 25
- 235000008434 ginseng Nutrition 0.000 claims abstract description 25
- 244000144730 Amygdalus persica Species 0.000 claims abstract description 23
- 244000303040 Glycyrrhiza glabra Species 0.000 claims abstract description 23
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims abstract description 23
- 244000197580 Poria cocos Species 0.000 claims abstract description 23
- 235000008599 Poria cocos Nutrition 0.000 claims abstract description 23
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 claims abstract description 21
- 235000011477 liquorice Nutrition 0.000 claims abstract description 21
- 244000181025 Rosa gallica Species 0.000 claims abstract description 17
- 235000000533 Rosa gallica Nutrition 0.000 claims abstract description 17
- MYSWGUAQZAJSOK-UHFFFAOYSA-N ciprofloxacin Chemical compound C12=CC(N3CCNCC3)=C(F)C=C2C(=O)C(C(=O)O)=CN1C1CC1 MYSWGUAQZAJSOK-UHFFFAOYSA-N 0.000 claims abstract description 15
- 241001633680 Polygonatum odoratum Species 0.000 claims abstract description 14
- 238000001914 filtration Methods 0.000 claims abstract description 13
- 241000196324 Embryophyta Species 0.000 claims abstract description 10
- 238000002386 leaching Methods 0.000 claims abstract description 10
- 239000008213 purified water Substances 0.000 claims abstract description 6
- 244000273928 Zingiber officinale Species 0.000 claims abstract 8
- 239000003814 drug Substances 0.000 claims description 23
- 239000007788 liquid Substances 0.000 claims description 22
- 239000000706 filtrate Substances 0.000 claims description 18
- 230000001580 bacterial effect Effects 0.000 claims description 16
- 241000213006 Angelica dahurica Species 0.000 claims description 14
- 240000006024 Lactobacillus plantarum Species 0.000 claims description 9
- 235000013965 Lactobacillus plantarum Nutrition 0.000 claims description 9
- 241000194020 Streptococcus thermophilus Species 0.000 claims description 9
- 238000000855 fermentation Methods 0.000 claims description 9
- 230000004151 fermentation Effects 0.000 claims description 9
- 235000013305 food Nutrition 0.000 claims description 9
- 229940072205 lactobacillus plantarum Drugs 0.000 claims description 9
- 241000675108 Citrus tangerina Species 0.000 claims description 8
- 241000756042 Polygonatum Species 0.000 claims description 8
- 241000220317 Rosa Species 0.000 claims description 8
- 244000269722 Thea sinensis Species 0.000 claims description 8
- 241000218231 Moraceae Species 0.000 claims description 7
- 239000000203 mixture Substances 0.000 claims description 6
- 238000003756 stirring Methods 0.000 claims description 6
- 241000193749 Bacillus coagulans Species 0.000 claims description 4
- 241001608472 Bifidobacterium longum Species 0.000 claims description 4
- 244000199866 Lactobacillus casei Species 0.000 claims description 4
- 235000013958 Lactobacillus casei Nutrition 0.000 claims description 4
- 241000186605 Lactobacillus paracasei Species 0.000 claims description 4
- 241000191998 Pediococcus acidilactici Species 0.000 claims description 4
- 241000191973 Staphylococcus xylosus Species 0.000 claims description 4
- 230000003213 activating effect Effects 0.000 claims description 4
- 229940054340 bacillus coagulans Drugs 0.000 claims description 4
- 229940009291 bifidobacterium longum Drugs 0.000 claims description 4
- 238000009924 canning Methods 0.000 claims description 4
- 229940017800 lactobacillus casei Drugs 0.000 claims description 4
- 238000000034 method Methods 0.000 claims description 4
- 238000002156 mixing Methods 0.000 claims description 4
- 230000001954 sterilising effect Effects 0.000 claims description 4
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 3
- 108010059892 Cellulase Proteins 0.000 claims description 3
- 240000001046 Lactobacillus acidophilus Species 0.000 claims description 3
- 235000013956 Lactobacillus acidophilus Nutrition 0.000 claims description 3
- 230000004913 activation Effects 0.000 claims description 3
- 238000009835 boiling Methods 0.000 claims description 3
- 229910052799 carbon Inorganic materials 0.000 claims description 3
- 229940106157 cellulase Drugs 0.000 claims description 3
- 238000010411 cooking Methods 0.000 claims description 3
- 239000000428 dust Substances 0.000 claims description 3
- FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical compound OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 claims description 3
- 229940107187 fructooligosaccharide Drugs 0.000 claims description 3
- 239000012535 impurity Substances 0.000 claims description 3
- 229940039695 lactobacillus acidophilus Drugs 0.000 claims description 3
- 241000416918 Polyphylla Species 0.000 claims description 2
- 241000208340 Araliaceae Species 0.000 claims 7
- 235000013399 edible fruits Nutrition 0.000 claims 6
- 210000004369 blood Anatomy 0.000 abstract description 58
- 239000008280 blood Substances 0.000 abstract description 58
- 230000001737 promoting effect Effects 0.000 abstract description 23
- 210000004185 liver Anatomy 0.000 abstract description 21
- 208000024891 symptom Diseases 0.000 abstract description 19
- 230000017531 blood circulation Effects 0.000 abstract description 15
- 230000001105 regulatory effect Effects 0.000 abstract description 14
- 230000006870 function Effects 0.000 abstract description 13
- 208000037093 Menstruation Disturbances Diseases 0.000 abstract description 8
- 206010027339 Menstruation irregular Diseases 0.000 abstract description 8
- 230000009286 beneficial effect Effects 0.000 abstract description 3
- 235000013361 beverage Nutrition 0.000 abstract description 3
- 244000131316 Panax pseudoginseng Species 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 24
- 241000234314 Zingiber Species 0.000 description 23
- 208000002193 Pain Diseases 0.000 description 20
- 240000004371 Panax ginseng Species 0.000 description 17
- 230000007812 deficiency Effects 0.000 description 15
- 230000002175 menstrual effect Effects 0.000 description 10
- 210000000952 spleen Anatomy 0.000 description 10
- 230000003821 menstrual periods Effects 0.000 description 9
- 230000001717 pathogenic effect Effects 0.000 description 9
- 239000000243 solution Substances 0.000 description 9
- 210000002784 stomach Anatomy 0.000 description 9
- 229940079593 drug Drugs 0.000 description 8
- 241000894006 Bacteria Species 0.000 description 6
- 208000005171 Dysmenorrhea Diseases 0.000 description 6
- 206010013935 Dysmenorrhoea Diseases 0.000 description 6
- 206010062717 Increased upper airway secretion Diseases 0.000 description 6
- 230000004087 circulation Effects 0.000 description 6
- 208000026435 phlegm Diseases 0.000 description 6
- 210000001015 abdomen Anatomy 0.000 description 5
- 206010016256 fatigue Diseases 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 230000005906 menstruation Effects 0.000 description 5
- 208000011580 syndromic disease Diseases 0.000 description 5
- 208000007536 Thrombosis Diseases 0.000 description 4
- 230000000202 analgesic effect Effects 0.000 description 4
- 230000003110 anti-inflammatory effect Effects 0.000 description 4
- 210000001124 body fluid Anatomy 0.000 description 4
- 239000010839 body fluid Substances 0.000 description 4
- 230000003203 everyday effect Effects 0.000 description 4
- 239000000284 extract Substances 0.000 description 4
- 230000001976 improved effect Effects 0.000 description 4
- 230000007774 longterm Effects 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 238000005728 strengthening Methods 0.000 description 4
- 230000002936 tranquilizing effect Effects 0.000 description 4
- 239000000341 volatile oil Substances 0.000 description 4
- 201000000736 Amenorrhea Diseases 0.000 description 3
- 206010001928 Amenorrhoea Diseases 0.000 description 3
- 208000006083 Hypokinesia Diseases 0.000 description 3
- 108090001005 Interleukin-6 Proteins 0.000 description 3
- 208000004880 Polyuria Diseases 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 231100000540 amenorrhea Toxicity 0.000 description 3
- 210000004204 blood vessel Anatomy 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 239000002131 composite material Substances 0.000 description 3
- 230000002950 deficient Effects 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 230000035619 diuresis Effects 0.000 description 3
- 208000002173 dizziness Diseases 0.000 description 3
- 230000004064 dysfunction Effects 0.000 description 3
- 230000002357 endometrial effect Effects 0.000 description 3
- 239000011521 glass Substances 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 208000007106 menorrhagia Diseases 0.000 description 3
- 244000052769 pathogen Species 0.000 description 3
- 238000010792 warming Methods 0.000 description 3
- 206010000060 Abdominal distension Diseases 0.000 description 2
- 206010013954 Dysphoria Diseases 0.000 description 2
- 201000009273 Endometriosis Diseases 0.000 description 2
- 208000019255 Menstrual disease Diseases 0.000 description 2
- 206010034568 Peripheral coldness Diseases 0.000 description 2
- 240000005809 Prunus persica Species 0.000 description 2
- 208000032140 Sleepiness Diseases 0.000 description 2
- 206010041349 Somnolence Diseases 0.000 description 2
- 208000005392 Spasm Diseases 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 210000000941 bile Anatomy 0.000 description 2
- 230000001914 calming effect Effects 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 210000002919 epithelial cell Anatomy 0.000 description 2
- 238000009499 grossing Methods 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 230000001965 increasing effect Effects 0.000 description 2
- 230000003340 mental effect Effects 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 238000010791 quenching Methods 0.000 description 2
- 230000002040 relaxant effect Effects 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 230000003860 sleep quality Effects 0.000 description 2
- 230000037321 sleepiness Effects 0.000 description 2
- 230000035882 stress Effects 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 230000035922 thirst Effects 0.000 description 2
- 210000001835 viscera Anatomy 0.000 description 2
- KJPRLNWUNMBNBZ-QPJJXVBHSA-N (E)-cinnamaldehyde Chemical compound O=C\C=C\C1=CC=CC=C1 KJPRLNWUNMBNBZ-QPJJXVBHSA-N 0.000 description 1
- 239000001606 7-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-5-hydroxy-2-(4-hydroxyphenyl)chroman-4-one Substances 0.000 description 1
- 208000000044 Amnesia Diseases 0.000 description 1
- 208000031091 Amnestic disease Diseases 0.000 description 1
- 208000019838 Blood disease Diseases 0.000 description 1
- 206010007191 Capillary fragility Diseases 0.000 description 1
- 244000037364 Cinnamomum aromaticum Species 0.000 description 1
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 description 1
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 208000035240 Disease Resistance Diseases 0.000 description 1
- 206010014080 Ecchymosis Diseases 0.000 description 1
- 206010049119 Emotional distress Diseases 0.000 description 1
- 208000036119 Frailty Diseases 0.000 description 1
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 1
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 1
- 235000017443 Hedysarum boreale Nutrition 0.000 description 1
- 235000007858 Hedysarum occidentale Nutrition 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- 206010027304 Menopausal symptoms Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 235000001188 Peltandra virginica Nutrition 0.000 description 1
- 206010034238 Pelvic adhesions Diseases 0.000 description 1
- 241001619461 Poria <basidiomycete fungus> Species 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- YURJSTAIMNSZAE-UHFFFAOYSA-N UNPD89172 Natural products C1CC(C2(CC(C3C(C)(C)C(O)CCC3(C)C2CC2O)OC3C(C(O)C(O)C(CO)O3)O)C)(C)C2C1C(C)(CCC=C(C)C)OC1OC(CO)C(O)C(O)C1O YURJSTAIMNSZAE-UHFFFAOYSA-N 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000006986 amnesia Effects 0.000 description 1
- 230000003474 anti-emetic effect Effects 0.000 description 1
- 230000002790 anti-mutagenic effect Effects 0.000 description 1
- 230000002785 anti-thrombosis Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 239000002111 antiemetic agent Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 230000001174 ascending effect Effects 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 238000000861 blow drying Methods 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 229940117916 cinnamic aldehyde Drugs 0.000 description 1
- KJPRLNWUNMBNBZ-UHFFFAOYSA-N cinnamic aldehyde Natural products O=CC=CC1=CC=CC=C1 KJPRLNWUNMBNBZ-UHFFFAOYSA-N 0.000 description 1
- 235000020965 cold beverage Nutrition 0.000 description 1
- 235000021270 cold food Nutrition 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 230000000916 dilatatory effect Effects 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 206010013990 dysuria Diseases 0.000 description 1
- 230000008451 emotion Effects 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 239000012259 ether extract Substances 0.000 description 1
- 235000011194 food seasoning agent Nutrition 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 235000002780 gingerol Nutrition 0.000 description 1
- 229940089161 ginsenoside Drugs 0.000 description 1
- 229930182494 ginsenoside Natural products 0.000 description 1
- YURJSTAIMNSZAE-HHNZYBFYSA-N ginsenoside Rg1 Chemical compound O([C@@](C)(CCC=C(C)C)[C@@H]1[C@@H]2[C@@]([C@@]3(C[C@@H]([C@H]4C(C)(C)[C@@H](O)CC[C@]4(C)[C@H]3C[C@H]2O)O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)C)(C)CC1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O YURJSTAIMNSZAE-HHNZYBFYSA-N 0.000 description 1
- CBEHEBUBNAGGKC-UHFFFAOYSA-N ginsenoside Rg1 Natural products CC(=CCCC(C)(OC1OC(CO)C(O)C(O)C1O)C2CCC3(C)C2C(O)CC4C5(C)CCC(O)C(C)(C)C5CC(OC6OC(CO)C(O)C(O)C6O)C34C)C CBEHEBUBNAGGKC-UHFFFAOYSA-N 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 239000001947 glycyrrhiza glabra rhizome/root Substances 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 208000014951 hematologic disease Diseases 0.000 description 1
- 208000018706 hematopoietic system disease Diseases 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000007365 immunoregulation Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000002718 inhibitory effect on inflammation Effects 0.000 description 1
- 230000002735 inhibitory effect on pain Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 229940010454 licorice Drugs 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 230000006996 mental state Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 244000000010 microbial pathogen Species 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 238000002703 mutagenesis Methods 0.000 description 1
- 231100000350 mutagenesis Toxicity 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- DFPMSGMNTNDNHN-ZPHOTFPESA-N naringin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](OC=2C=C3O[C@@H](CC(=O)C3=C(O)C=2)C=2C=CC(O)=CC=2)O[C@H](CO)[C@@H](O)[C@@H]1O DFPMSGMNTNDNHN-ZPHOTFPESA-N 0.000 description 1
- 229940052490 naringin Drugs 0.000 description 1
- 229930019673 naringin Natural products 0.000 description 1
- 201000009240 nasopharyngitis Diseases 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 230000007180 physiological regulation Effects 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 239000010666 rose oil Substances 0.000 description 1
- 235000019719 rose oil Nutrition 0.000 description 1
- 230000001624 sedative effect Effects 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 230000000391 smoking effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 230000004206 stomach function Effects 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 230000008093 supporting effect Effects 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 208000016255 tiredness Diseases 0.000 description 1
- 230000003867 tiredness Effects 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 230000009278 visceral effect Effects 0.000 description 1
- 230000007371 visceral function Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/38—Other non-alcoholic beverages
- A23L2/382—Other non-alcoholic beverages fermented
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L31/00—Edible extracts or preparations of fungi; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
- A61K36/605—Morus (mulberry)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/738—Rosa (rose)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8969—Polygonatum (Solomon's seal)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9062—Alpinia, e.g. red ginger or galangal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9068—Zingiber, e.g. garden ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
- A61K2236/19—Preparation or pretreatment of starting material involving fermentation using yeast, bacteria or both; enzymatic treatment
Abstract
本发明公开了一种药食同源发酵饮品及其制备方法,饮品包括桑葚3~9份、桃仁3~9份、玉竹3~9份、橘红3~9份、重瓣红玫瑰3~9份、种植人参3~9份、肉桂3~9份、高良姜3~9份、干姜3~9份、茯苓3~9份、白芷3~9份、甘草3~9份、纯化水50~70份。制备方法包括:原料前处理、植物浸提液制备、发酵、过滤。本发明的有益效果是:具有祛风散寒、疏肝理气、活血化瘀、补气补血的作用,可从根本上改善女性气血问题,从而改善女性的痛经、月经不调等症状。
Description
技术领域
本发明属于饮料加工技术领域,尤其涉及一种药食同源发酵饮品及其制备方法。
背景技术
《素问·刺法论》说:“正气存内,邪不可干”。反之,当人体正气不足,或正气相对虚弱时,卫外功能低下,往往抗邪无力,则邪气可能乘虚而入,导致机体阴阳失调,脏腑经络功能紊乱,以致引发疾病。故《素问·评热病论》说:“邪之所凑,其气必虚”。正气抗御外邪入侵的这一功能,与免疫功能的防御作用,即抵御病原微生物感染的作用相当。正气的抗病能力还表现为维持脏腑功能的协调、气血的流行畅达。在中医病因学中,特别注意内生邪气,如痰饮、瘀血以及内生五邪等。上述邪气,往往是脏腑功能失调,气血失和的病理产物,又反过来影响人体,导致疾病的发生。
当代女性尤其是年轻女性,因过度减肥、过度熬夜、喝酒、抽烟、精神压力大、喜爱喝冰冷、先天遗传因素(肾气不足)等因素,导致身体气虚,气血不畅,易出现痛经,月经不调等症状。引发月经不调的主要原因就是人体正气不足,正气不足会导致“气血虚弱”、“寒湿凝滞”、“气滞血瘀”、“湿热下注”。
目前市场上针对女性生理调节相关的饮品,比如红糖姜茶,其只对有寒症的女性有一些调养效果,对于具有“虚”、“瘀”、“热”等症状的女性无调养效果;其不能补充正气,也不能活血化瘀、疏肝理气、解表散寒,而只有当人体正气充足,才不易受外邪侵入,才不会出现“气血虚弱”、“寒湿凝滞”、“气滞血瘀”、“湿热下注”(简称:“虚”、“寒”、“瘀”、“热”)等症状。“气血虚弱”的女性,通常体现症状包括经量过大,第一天第二天经量过大,第三天开始经量变得特别少,腰酸腿软、小腹隐隐作痛,身体时常出虚汗,容易疲劳、累、头晕,经量过少而淡红,嘴唇白、指甲白、没有血色,舌下血管细而短,一般舌头颜色淡。“气滞血瘀”的女性通常体现症状包括经期有血块、颜色暗红、经前烦躁、经前或经期胸部胀痛;舌下嘴唇深或黑紫;血管深紫色、黑色,凸起严重;脸上暗斑、色素沉淀,气血运行不畅、肝气郁结;舌下血管深紫色、黑色,凸起严重;嘴唇黑。体寒的女性通常体现症状包括经量少、但色鲜艳;小腹凉、经期冷痛;手脚冰冷。现有的用于女性生理调节相关的饮品所用的药食同源材料相互协调性差,甚至部分材料是相冲的,比如温性药和滋阴药相冲,导致正气补充不足,从而无法从根本上解决痛经,月经不调等症状。
发明内容
本发明的目的在于克服现有技术的缺陷,提供了一种药食同源发酵饮品及其制备方法。
为实现上述目的,本发明所设计的药食同源发酵饮品,通过以下重量份原料制成:桑葚3~9份、桃仁3~9份、玉竹3~9份、橘红3~9份、重瓣红玫瑰3~9份、种植人参3~9份、肉桂3~9份、高良姜3~9份、干姜3~9份、茯苓3~9份、白芷3~9份、甘草3~9份、纯化水50~70份。
进一步,按重量份计,所述桑葚9份、桃仁9份、玉竹3份、橘红3份、重瓣红玫瑰3份、种植人参9份、肉桂9份、高良姜3份、干姜3份、茯苓3份、白芷3份、甘草3份。
进一步,按重量份计,所述桑葚3份、桃仁3份、玉竹9份、橘红9份、重瓣红玫瑰9份、种植人参3份、肉桂3份、高良姜9份、干姜9份、茯苓9份、白芷9份、甘草9份。
进一步,按重量份计,所述桑葚8份、桃仁5份、玉竹6份、橘红6份、重瓣红玫瑰3份、种植人参9份、肉桂7份、高良姜8份、干姜6份、茯苓8份、白芷9份、甘草9份。
进一步,按重量份计,所述桑葚6份、桃仁4份、玉竹9份、橘红9份、重瓣红玫瑰5份、种植人参7份、肉桂3份、高良姜4份、干姜4份、茯苓3份、白芷4份、甘草5份。
进一步,按重量份计,所述桑葚8份、桃仁9份、玉竹9份、橘红5份、重瓣红玫瑰3份、种植人参7份、肉桂3份、高良姜4份、干姜8份、茯苓3份、白芷5份、甘草5份。
进一步,按重量份计,还包括1~2份菌液。
进一步,所述菌液为长双歧杆菌、嗜酸乳杆菌、干酪乳杆菌、副干酪乳杆菌、植物乳杆菌、嗜热链球菌、乳酸片球菌、木糖葡萄球菌、凝结芽孢杆菌中的一种或多种。
进一步,所述菌液为植物乳杆菌和嗜热链球菌。
本发明的有益效果是:种植人参具有补气养阴,生津安神的特性;桃仁、重瓣玫瑰花、桑椹具有调经补血,疏肝理气,活血止痛,润肠通便的特性;肉桂、干姜、高良姜、白芷温中散寒止痛,辛散温通,燥湿止带;茯苓、玉竹、橘红利水渗湿,健脾补中,燥湿化痰,可清肺胃之热,健脾运胃,增强其消化吸收的能力,气血得以化生;甘草具有缓急止痛,调和的作用。将上述12种药食同源材料按特定比例制备的本发明的饮品具有疏肝理气、活血化瘀、补气补血的作用,可从根本上改善女性气血问题,从而改善女性的痛经、月经不调等症状。
本发明还公开了一种制备药食同源发酵饮品的方法,包括以下步骤:
S1、原料前处理:去除原料中杂质和异物后,将原料置于90℃热水中浸没10秒以去除原料表面尘土;其中,所述原料包括以下重量份:桑葚3~9份、桃仁3~9份、玉竹3~9份、橘红3~9份、重瓣红玫瑰3~9份、种植人参3~9份、肉桂3~9份、高良姜3~9份、干姜3~9份、茯苓3~9份、白芷3~9份、甘草3~9份;
S2、植物浸提液制备:
将所述步骤S1处理后的原料投入蒸煮罐中,并加入45℃的水和0.2%的纤维素酶,恒温搅拌,静止2小时后过滤得到第一滤液和第一滤渣;其中,所述原料和水的比例为1∶5;
向所述第一滤渣中加入8倍量的65℃的水,恒温搅拌,静止1小时后过滤得到第二滤液和第二滤渣;
向所述第二滤渣中加入8倍量的100℃的水,煮沸1小时,过滤得到第三滤液;
将所述第一滤液、第二滤液和第三滤液合并混合,得到植物浸提液;
S3、发酵:将所述步骤S2的所述植物浸提液转入发酵罐中,并投入6%的低聚果糖作为碳源,并投入菌液后,在40℃发酵三天;其中,发酵过程中每天搅拌两次;所述菌液为0.05%的植物乳杆菌和0.05%的嗜热链球菌在无菌环境下于活化罐内活化1h而得;
S4、将所述步骤S3发酵完成后的液体过滤,并进行罐装和杀菌,制得所述药食同源发酵饮品。
本发明的有益效果是:通过上述制备方法制备的药食同源发酵饮品,不仅具有良好的口感,而且各原料的有效成分被充分提取,具有疏肝理气、活血化瘀、补气补血的作用,可从根本上改善女性气血问题,从而改善女性的痛经、月经不调等症状。
附图说明
图1为本发明药食同源发酵饮品制备方法的流程示意图。
具体实施方式
以下结合附图和具体实施例对本发明作进一步的详细描述。
实施例1
一种药食同源发酵饮品:按重量份计,包括以下原料:桑葚9份、桃仁9份、玉竹3份、橘红3份、重瓣红玫瑰3份、种植人参9份、肉桂9份、高良姜3份、干姜3份、茯苓3份、白芷3份、甘草3份、纯化水50份、1~2份菌液。菌液为长双歧杆菌、嗜酸乳杆菌、干酪乳杆菌、副干酪乳杆菌、植物乳杆菌、嗜热链球菌、乳酸片球菌、木糖葡萄球菌、凝结芽孢杆菌中的一种或多种。本实施例中优选为植物乳杆菌1份和嗜热链球菌1份。
本实施例的发酵饮品的制备方法为:取8份桑葚单独发酵,再将上述另外的11种药食同源材料和另外1份桑葚混合发酵,最后利用单独发酵的桑葚原液进行调味。
种植人参(以下也简称人参)中的人参皂苷可以增强血液循环、抗氧化、增强免疫力、改善疲劳、增强记忆力、改善更年期症状,健康滋养延缓衰老,改善体质增强活力。人参皂苷Rg1还可以对广泛的炎症和疼痛起到明显的抑制作用。
桃仁具有活血祛痰,润肠通便等功效。用于经闭,痛经,癜瘕痞块,跌打损伤,肠燥便秘。桃仁有很好的破血行瘀的作用,用来改善闭经和痛经。
肉桂具有补火助阳,散寒止痛,温经通脉的功效。现代医学证明肉桂含有的桂皮醛对中枢神经系统有明显的镇静作用。大量的桂皮油还可以引起子宫充血,起到明显的通经作用。
干姜提取物有镇静、镇痛、抗炎、止呕,并且明显增加肝脏胆汁分泌量及短暂升高血压的作用。干姜挥发油还可以延缓血栓的形成。干姜的镇痛抗炎成分主要是脂溶性姜酚类,干姜醚提物和水提物也都具有显著镇痛抗炎作用。
高良姜的水提取物和挥发油有镇痛抗炎、抗血栓形成和抗菌作用。
茯苓其主要成分是茯苓多糖,可以促进血液循环、新陈代谢。临床上多用于治疗小便不利,水肿,目眩心悸,脾胃虚弱,倦怠乏力,失眠健忘等病症。并具有免疫调节功能,通过动态调节体内诸如细胞因子之类的信号分子,调节机体的免疫能力。
白芷具有解表散寒,辛散温通,祛风止痛止痒,宣通鼻窍,燥湿止带,消肿排脓的功效。
玉竹补而不腻,不寒不燥,故有“清热润肺,养阴熄风,补益五脏,滋养气血,平补而润,兼除风热”之功效,作用于脾胃,故久服不伤脾胃。玉竹提取物C(EC—PAOA)可降低多功能细胞因子IL一6和子宫内膜上皮细胞特异性蛋白CA一125的表达。IL一6是与子宫内膜异位关系最密切的细胞因子,IL一6的降低可减少对子宫内膜增殖的刺激作用,从而减少病灶处新生血管形成,加速异位病灶的坏死,促进局部炎症的吸收,减轻盆腔粘连;CA一125为内膜上皮细胞特异性蛋白CA一125的降低,说明异位细胞的生长受到阻碍,子宫内膜异位的发展得到了有效控制。
橘红具有理气宽中,燥湿化痰的作用。橘红的提取物柚皮苷是一种双氢黄酮类化合物,具有多种生物活性和药理作用,如抗氧化、抗突变、抗肿瘤、抑菌、改善微循环、降低毛细血管的脆性等。
重瓣红玫瑰的提取物玫瑰油有促进胆汁分泌作用,其挥发油具有美白、抗氧化等作用。挥发油类化合物具有芳香开窍、活血行气、扩张心血管、改善内脏及外周血液循环的作用。
甘草在本实施例中起调和作用,协调寒热,平调升降。
桑葚具有滋阴补血,生津止渴,安魂镇神等功效,其因含有桑葚多糖而具有多种功能作用,如降血脂、降血糖、护肝、防癌、抗突变、抗诱变、抗衰老等。
本实施例中,人参既可补气养阴,又可生津安神,当为君药。桃仁、玫瑰花、桑椹共奏调经补血,疏肝理气之效,并且活血止痛,润肠通便,伴为臣药。肉桂、干姜、高良姜、白芷温中散寒止痛,辛散温通,燥湿止带,引火归源的功效辅佐君药。肝气郁滞会导致肝木克脾土,茯苓、玉竹、橘红利水渗湿,健脾补中,燥湿化痰,又可清肺胃之热;健脾运胃,增强其消化吸收的能力,气血得以化生,当为使药。又有甘草缓急止痛,调和诸药。
本产品主要功效是疏肝理气、活血化瘀、补气补血、从根本上改善女性正气不足导致的气血问题,从而改善女性的月经不调各种症状(比如:痛经、手脚冰冷、月经不准时、经前烦躁、量过大、量过少)。
对于“气血虚弱”的人群,可通过人参和肉桂调养,人参:大补元气、复脉固脱、补脾益肺、安神益智;肉桂:补肾阳;肾气充足,则正气足。
对于“寒湿凝滞”的人群,可通过肉桂、干姜、高良姜和白芷调养;正气不足的人,寒邪就会进入,寒邪除了体表的冷寒气,吃生冷食物,也会有寒邪;另外,本身寒体质的人,由于阴阳不平衡或阳气不足,也会有寒邪,而这需要肉桂来补阳气、温经通脉、引火归元。
同时,干姜和高良姜都可使体内寒邪排出,通经驱寒,温中祛寒的,相须为用,效果更好。高良姜散寒效果比干姜好,可以增长整体的驱寒效果,但干姜却可以回阳通脉;而白芷可祛风、解表散寒;肉桂可以把上焦的虚火引下来,还可以驱下焦寒。
相比现有的红糖姜茶(一般用干姜和红糖),虽然红糖也有祛风散寒的作用,但是效果并没有高良姜作用大。而对于寒症的人,不仅要驱寒,还要补充正气,否则,其依然会有寒症,这就是现有红糖姜茶类饮品无法解决女性月经不调问题的根本原因。因此,需要配合本实施例中的其他原料补充人体正气。
对于“气滞血瘀”的人群而言,其不仅是因为正气不足,还因为肝气郁滞,造成血瘀。肝主疏泄而藏血,具有条达气机,调节情志的功能,情志不遂或外邪侵袭肝脉则肝气郁滞,疏泄失职,故情绪抑郁或急躁,胸胁胀闷,走窜疼痛;气为血帅,肝郁气滞,日久不解,必致瘀血内停,故渐成胁下痞块,刺痛拒按;肝主藏血,为妇女经血之源,肝血瘀滞,瘀血停滞,积于血海,阻碍经血下行,经血不畅则致经闭、痛经。舌质紫暗或有瘀斑,脉涩,均为瘀血内停之症。也正是因为正气不足,气虚而导致血形成淤堵。
重瓣红玫瑰:疏肝行气,活血止痛,针对气滞血瘀,重瓣红玫瑰主要强在行气的功效,行气这里指的是行肝气;桃仁:主要强在活血化瘀,所以对于气滞血瘀的人,首先要先把肝气疏通,然后还要用桃仁把它之前留下来的血淤化掉和去除。
对于“湿热下注”的人群而言,这里的“热”指的是,中焦不通,中焦不通的人就没法运化水谷、化生气血,中焦不通会引起湿热下注,湿热下注指湿热聚集在下焦,常见症状是经前小腹疼痛,身重疲乏,容易累,因此,解决“湿热下注”就需要疏通中焦,即用茯苓:利水渗湿、益脾和胃;用玉竹:生津止渴、清胃热、除风热;用橘红:理气宽中、疏通中焦、燥湿化痰来排湿。
如图1所示,本实施例的药食同源发酵饮品的制备方法如下:
S1、原料前处理:去除原料中杂质和异物后,将原料置于90℃热水中浸没10秒以去除原料表面尘土;
S2、植物浸提液制备:
将所述步骤S1处理后的原料投入蒸煮罐中,并加入45℃的水和0.2%的纤维素酶,恒温搅拌,静止2小时后过滤得到第一滤液和第一滤渣;其中,所述原料和水的比例为1∶5;
向所述第一滤渣中加入65℃的水中,其中,第一滤渣和水的比例为1∶8,恒温搅拌,静止1小时后过滤得到第二滤液和第二滤渣;
向所述第二滤渣中加入100℃的水,其中,第二滤渣和水的比例为1∶8,煮沸1小时,过滤得到第三滤液;
将所述第一滤液、第二滤液和第三滤液合并混合,得到植物浸提液;
S3、发酵:将所述步骤S2的所述植物浸提液转入发酵罐中,并投入6%的低聚果糖作为碳源,并投入菌液后,在40℃发酵三天;其中,发酵过程中每天搅拌两次;所述菌液为0.05%的植物乳杆菌和0.05%的嗜热链球菌在无菌环境下于活化罐内活化1h而得;
S4、将所述步骤S3发酵完成后的液体过滤,并进行罐装和杀菌,制得所述药食同源发酵饮品,其中,罐装用的玻璃瓶需经过洗瓶、吹干和臭氧消毒工艺;杀菌为罐装后的玻璃瓶置于105℃环境下持续30分钟;杀菌后的玻璃瓶进行包装后入库。
本实施例的配方整体偏温性,为了使其更平稳和平和,还需用其他药来中和,用桑葚:滋阴润燥、滋阴补血;用玉竹:养阴润燥。最后再用甘草来调和诸药,协调寒热、平调升降,让所有的药更融合一起发挥作用,从而在根本上改善女性气血问题,改善女性的痛经、月经不调等症状。
个案报道:
案例1:
宛女士,26岁,职业:服务业。自述长期的作息不太规律,每次月经期经量都会很多,能很明显的感觉到经血下坠,并且伴随有痛经,腰部酸胀,头晕无力的感觉,而月经期以外也经常出现乏力症状。自经前14天开始每天服用50ml(袋装为一袋)本实施例的药食同源发酵饮品,并持续一个月后,精神气相较于以前有所改善,乏力的症状消失,经量变得正常,腰部酸胀有改善,并排出了血块和污血,连续服用两个月后,痛经和腰部酸胀感逐渐消失,精力变得旺盛。
案例2:
吴女士,28岁,学生。由于精神压力大以及长期熬夜,经期前两天量很大,痛感明显,人也很虚弱,皮肤暗黄无光泽,每天服用50ml本实施例的药食同源发酵饮品,并持续15天后,经量变得正常,痛感渐缓,皮肤能明显感觉出有改善,精神也更好。
案例3:
张女士,27岁,职业:护士。由于长期的睡眠不规律以及熬夜,造成了内分泌的紊乱和经期的淤堵,经前脸上都会长很多痘痘,每日一袋(50ml)连续服用14天后,开始排出体内的淤堵,排出血块后,脸部的痘痘有明显的消退,睡眠相较于以前也好了很多。
案例4:
王女士,25岁,职业:文员。平时睡眠质量差,经期来临之前和之后都会出现痛经症状,连续服用本实施例的药食同源发酵饮品3天后,睡眠质量有所提升,相比此前凌晨失眠无困意,现在晚上九点左右就会产生困意;连续服用五天后,经期疼痛感减弱。
案例5:
李女士,24岁,销售。平时爱喝冷饮,工作压力较大,每次月经期间都会出现无精神及下腹坠痛的症状,经前服用本实施例的药食同源发酵饮品14天,每日一袋(50ml)后,下个经期时,下腹坠痛感消失,精神状态更好。
实施例2
一种药食同源发酵饮品:按重量份计,包括以下原料:桑葚3份、桃仁3份、玉竹9份、橘红9份、重瓣红玫瑰9份、种植人参3份、肉桂3份、高良姜9份、干姜9份、茯苓9份、白芷9份、甘草9份、纯化水70份、长双歧杆菌1份。本实施例的药食同源发酵饮品的制备方法与实施例1相同,区别在于上述原料的组分不同和菌液不同,其中菌液的制备方法相同。
实施例3
一种药食同源发酵饮品:按重量份计,包括以下原料:桑葚8份、桃仁5份、玉竹6份、橘红6份、重瓣红玫瑰3份、种植人参9份、肉桂7份、高良姜8份、干姜6份、茯苓8份、白芷9份、甘草9份、纯化水60份、干酪乳杆菌1份、副干酪乳杆菌1份。本实施例的药食同源发酵饮品的制备方法与实施例1相同,区别在于上述原料的组分不同和菌液不同,其中菌液的制备方法相同。
实施例4
本实施例的药食同源发酵饮品的原料与实施例1大致相同,区别在于:按重量份计,桑葚6份、桃仁4份、玉竹9份、橘红9份、重瓣红玫瑰5份、种植人参7份、肉桂3份、高良姜4份、干姜4份、茯苓3份、白芷4份、甘草5份、乳酸片球菌1份、木糖葡萄球菌0.5份、凝结芽孢杆菌中0.5份。本实施例的药食同源发酵饮品的制备方法与实施例1相同,区别在于上述原料的组分不同和菌液不同,其中菌液的制备方法相同。
实施例5
本实施例的药食同源发酵饮品的原料与实施例1大致相同,区别在于:按重量份计,桑葚8份、桃仁9份、玉竹9份、橘红5份、重瓣红玫瑰3份、种植人参7份、肉桂3份、高良姜4份、干姜8份、茯苓3份、白芷5份、甘草5份。本实施例的药食同源发酵饮品的制备方法与实施例1相同,区别在于上述原料的组分不同。
以上所述仅是本发明的优选实施方式,本发明的保护范围并不仅局限于上述实施例,凡属于本发明思路下的技术方案均属于本发明的保护范围。应当指出,对于本技术领域的普通技术人员来说,在不脱离本发明原理前提下的若干改进和润饰,同样也应视为本发明的保护范围。
Claims (10)
1.一种药食同源发酵饮品,其特征在于:通过以下重量份原料制成:桑葚3~9份、桃仁3~9份、玉竹3~9份、橘红3~9份、重瓣红玫瑰3~9份、种植人参3~9份、肉桂3~9份、高良姜3~9份、干姜3~9份、茯苓3~9份、白芷3~9份、甘草3~9份、纯化水50~70份。
2.根据权利要求1所述的一种药食同源发酵饮品,其特征在于:按重量份计,所述桑葚9份、桃仁9份、玉竹3份、橘红3份、重瓣红玫瑰3份、种植人参9份、肉桂9份、高良姜3份、干姜3份、茯苓3份、白芷3份、甘草3份。
3.根据权利要求1所述的一种药食同源发酵饮品,其特征在于:按重量份计,所述桑葚3份、桃仁3份、玉竹9份、橘红9份、重瓣红玫瑰9份、种植人参3份、肉桂3份、高良姜9份、干姜9份、茯苓9份、白芷9份、甘草9份。
4.根据权利要求1所述的一种药食同源发酵饮品,其特征在于:按重量份计,所述桑葚8份、桃仁5份、玉竹6份、橘红6份、重瓣红玫瑰3份、种植人参9份、肉桂7份、高良姜8份、干姜6份、茯苓8份、白芷9份、甘草9份。
5.根据权利要求1所述的一种药食同源发酵饮品,其特征在于:按重量份计,所述桑葚6份、桃仁4份、玉竹9份、橘红9份、重瓣红玫瑰5份、种植人参7份、肉桂3份、高良姜4份、干姜4份、茯苓3份、白芷4份、甘草5份。
6.根据权利要求1所述的一种药食同源发酵饮品,其特征在于:按重量份计,所述桑葚8份、桃仁9份、玉竹9份、橘红5份、重瓣红玫瑰3份、种植人参7份、肉桂3份、高良姜4份、干姜8份、茯苓3份、白芷5份、甘草5份。
7.根据权利要求1~6任一项所述的一种药食同源发酵饮品,其特征在于:按重量份计,还包括1~2份菌液。
8.根据权利要求7所述的一种药食同源发酵饮品,其特征在于:所述菌液为长双歧杆菌、嗜酸乳杆菌、干酪乳杆菌、副干酪乳杆菌、植物乳杆菌、嗜热链球菌、乳酸片球菌、木糖葡萄球菌、凝结芽孢杆菌中的一种或多种。
9.根据权利要求7所述的一种药食同源发酵饮品,其特征在于:所述菌液为植物乳杆菌和嗜热链球菌。
10.一种制备如权利要求1所述药食同源发酵饮品的方法,其特征在于:包括以下步骤:
S1、原料前处理:去除原料中杂质和异物后,将原料置于90℃热水中浸没10秒以去除原料表面尘土;其中,所述原料包括以下重量份:桑葚3~9份、桃仁3~9份、玉竹3~9份、橘红3~9份、重瓣红玫瑰3~9份、种植人参3~9份、肉桂3~9份、高良姜3~9份、干姜3~9份、茯苓3~9份、白芷3~9份、甘草3~9份;
S2、植物浸提液制备:
将所述步骤S1处理后的原料投入蒸煮罐中,并加入45℃的水和0.2%的纤维素酶,恒温搅拌,静止2小时后过滤得到第一滤液和第一滤渣;其中,所述原料和水的比例为1∶5;
向所述第一滤渣中加入8倍量的65℃的水,恒温搅拌,静止1小时后过滤得到第二滤液和第二滤渣;
向所述第二滤渣中加入8倍量的100℃的水,煮沸1小时,过滤得到第三滤液;
将所述第一滤液、第二滤液和第三滤液合并混合,得到植物浸提液;
S3、发酵:将所述步骤S2的所述植物浸提液转入发酵罐中,并投入6%的低聚果糖作为碳源,并投入菌液后,在40℃发酵三天;其中,发酵过程中每天搅拌两次;所述菌液为0.05%的植物乳杆菌和0.05%的嗜热链球菌在无菌环境下于活化罐内活化1h而得;
S4、将所述步骤S3发酵完成后的液体过滤,并进行罐装和杀菌,制得所述药食同源发酵饮品。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011003831.6A CN112136993A (zh) | 2020-09-22 | 2020-09-22 | 一种药食同源发酵饮品及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011003831.6A CN112136993A (zh) | 2020-09-22 | 2020-09-22 | 一种药食同源发酵饮品及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN112136993A true CN112136993A (zh) | 2020-12-29 |
Family
ID=73897111
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202011003831.6A Pending CN112136993A (zh) | 2020-09-22 | 2020-09-22 | 一种药食同源发酵饮品及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN112136993A (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN116459327A (zh) * | 2023-05-30 | 2023-07-21 | 江苏益骨堂生物科技有限公司 | 一种三焦本草发酵液的制备方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108685094A (zh) * | 2018-05-23 | 2018-10-23 | 青岛康迈臣生物科技有限责任公司 | 一种中药酵素及其制备方法 |
CN109090410A (zh) * | 2018-09-28 | 2018-12-28 | 杨声显 | 一种活体中药复合益生菌饮品及其制备方法 |
CN110507803A (zh) * | 2019-09-20 | 2019-11-29 | 徐州三源医药科技集团有限公司 | 一种气血调和膏及其制备方法 |
-
2020
- 2020-09-22 CN CN202011003831.6A patent/CN112136993A/zh active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108685094A (zh) * | 2018-05-23 | 2018-10-23 | 青岛康迈臣生物科技有限责任公司 | 一种中药酵素及其制备方法 |
CN109090410A (zh) * | 2018-09-28 | 2018-12-28 | 杨声显 | 一种活体中药复合益生菌饮品及其制备方法 |
CN110507803A (zh) * | 2019-09-20 | 2019-11-29 | 徐州三源医药科技集团有限公司 | 一种气血调和膏及其制备方法 |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN116459327A (zh) * | 2023-05-30 | 2023-07-21 | 江苏益骨堂生物科技有限公司 | 一种三焦本草发酵液的制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103263608B (zh) | 一种排毒养颜的中药原粉 | |
CN102511867B (zh) | 红枣阿胶枸杞浓浆及其生产工艺 | |
CN104531477A (zh) | 一种牡丹养肾酒及其制备方法 | |
CN102987477B (zh) | 一种保健饮料 | |
CN103211930B (zh) | 一种降血脂、降血压的中药制剂 | |
CN102511866A (zh) | 红枣阿胶浓浆及其生产工艺 | |
CN112136993A (zh) | 一种药食同源发酵饮品及其制备方法 | |
KR20160000695A (ko) | Dha 함유 기억력 강화 및 피로회복 증진용 한약재 조성물 수능환 및 그 제조방법 | |
CN104783174A (zh) | 一种纯天然营养免疫保健固体饮料的配制方法 | |
CN104187246A (zh) | 一种功能性红糖及其制备方法 | |
CN114053370A (zh) | 一种养肝护肝中药配方及其制备方法与应用 | |
CN102670974B (zh) | 一种养生保健酒 | |
CN104922504A (zh) | 治疗动脉粥样硬化的醋饮及制备方法 | |
CN111870630A (zh) | 一种用于增加抵抗力和免疫力的药物配方及制备工艺 | |
CN110585373A (zh) | 一种补气养血茶及其制备方法 | |
CN110123994B (zh) | 改善气郁体质的中药组合物、佛手薄荷膏及制备方法 | |
CN103110783A (zh) | 一种治疗脑萎缩的药物 | |
CN106879775A (zh) | 一种产后苗条袋泡茶及其制备方法 | |
CN106367257A (zh) | 一种益气活血山楂酒的制备方法 | |
CN105454760A (zh) | 一种酸枣仁米粥的制备方法 | |
CN105582400A (zh) | 一种生源壮酒及其制备方法 | |
CN104984119A (zh) | 一种母犬专用营养软膏及其制备方法 | |
CN1141172A (zh) | 一种滋补保健酒 | |
CN113749240A (zh) | 一种助眠葱白水及其制备工艺 | |
CN104293612A (zh) | 一种黄皮果白雪耳雪梨保健补酒 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20201229 |